𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EEG- and cognitive changes in Alzheimer's disease (AD) and senile dementia of AD-type (SDAT)

✍ Scribed by M. Streifler; M. Simanyi; P. Fischer; W. Danielczyk

Publisher
Springer
Year
1989
Tongue
English
Weight
63 KB
Volume
1
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical trials with the cholinergic dru
Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)
✍ Albert Wettstein; RenΓ© Spiegel πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e